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INTRODUCTION
 Effective management of postoperative pain 
is main challenging for anaesthesiologists and 
clinicians despite impressive advances in analgesic 
drugs and techniques. One of the most important 
factors influencing patient safety, comfort and early 
discharge is effective postoperative pain control.1
 Opioids are analgesic agents with proven efficacy 
and their administration has been a conventional 
method of pain control for many years. However, 
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ABSTRACT
Background and Objective: Septoplasty	operations	are	associated	with	moderate	to	severe	postoperative	
pain	which	has	unfavourable	effects	on	patient’s	 recovery	and	postoperative	outcome.	The	aim	of	this	
study	was	to	compare	effects	of	intravenous	paracetamol	and	dexketoprofen	on	postoperative	analgesia,	
tramadol	consumption	and	side	effects	after	septoplasty.
Methods:	In	total	72	patients	(aged	18–65	years)	who	had	undergone	an	elective	septoplasty	from	August	
2013	to	January	2015	in	Baskent	University	Faculty	of	Medicine,	in	the	Department	of	Anesthesiology	and	
Reanimation	Clinics	were	included	in	this	study. The	patients	were	randomised	into	one	of	two	groups:	
those	 who	 received	 intravenous	 paracetamol;	 and	 those	 who	 received	 intravenous	 dexketoprofen.	All	
patients	were	treated	with	tramadol	for	24	hour	postoperatively.	The	primary	endpoint	was	pain	intensity	
as	measured	by	a	visual	analogue	scale	(VAS).	Tramadol	consumption	and	drug	related	side	effects	were	
also recorded.
Results:	The	pain	scores	in	the	dexketoprofen	group	were	significantly	lower	at	recovery,	15	and	30	minutes	
and	two	hour	(p<	0.05).	The	pain	scores	had	no	difference	at	other	time	points.	Tramadol	consumption	in	the	
recovery	period	was	significantly	lower	in	the	dexketoprofen	group,	but	cumulative	tramadol	consumption	
did	not	differ	between	the	groups.	The	incidence	of	nausea	was	lower	but	not	statistically	significant	in	the	
dexketoprofen	group	at	15	and	30	minutes	and	two	hour.	
Conclusions:	Compared	with	paracetamol,	preemptive	dexketoprofen	is	associated	with	lower	VAS	scores	
and	tramadol	consumption	in	the	early	postoperative	period	after	septoplasty.	However,	the	cumulative	
tramadol	consumption	did	not	significantly	differ	between	the	groups.
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large bolus doses of potent opioids are now being 
used less frequently because of dose-dependent 
side effects and increased incidence of opioid 
base postoperative complications.2 In addition 
to these complications, inadequate treatment of 
pain is another cause of long-term hospitalisation, 
unexpected hospital admissions after surgery and 
increase health care costs.3 Considering these side 
effects, the use of balance multimodal analgesic 
protocols involving smaller doses of opioids in 
combination with non-opioid analgesic drugs (such 
as Nonsteroidal anti-inflammatory drugs [NSAIDS], 
paracetamol, and local anaesthetics) has become a 
widely accepted approach both during and after 
surgery.4,5 
 Newly improved agents are used in clinical 
practice for the treatment of moderate and severe 
pain when administered orally, intramusculary, 
and intravenously.6  In recent years, two such drugs 
investigated in previous studies intravenous forms 
of paracetamol7 and dexketoprofen8 have played 
an important role in postoperative pain relief in 
the clinical setting. Paracetamol is among the most 
commonly used analgesic agents because of its 
safety and favourable side effects in postoperative 
pain management. Previous studies have shown 
that, paracetamol allows for decreased opioid 
consumption after different surgical procedures.7,9 
 Dexketoprofen trometamol is an active 
enantiomer of racemic ketoprofen and, centrally 
acting NSAID. Like other nonsteroidal agents, 
dexketoprofen has analgesic, anti-pyretic and 
anti-inflammatory properties.10 It’s advantages 
can be listed as faster onset of action and more 
potency and less gastrointestinal side effects when 
compared to ketoprofen and other NSAID’s. 
Although intravenous dexketoprofen trometamol 
has been used and compared with paracetamol in 
postoperative pain treatment in different surgeries, 
there are not enough studies on dexketoprofen 
paracetamol and opioid combination in patient 
controlled analgesia technique.
 In present study, our primary endpoint was 
to compare the analgesic efficacy and side 
effect profile of dexketoprofen trometamol and 
paracetamol in patients with septoplasty when they 
were combined with intravenous tramadol patient 
controlled analgesia.
METHODS
 This study was approved by the Baskent 
University Institutional Ethics Committee (Project 
no. KA13/100) and Trial registration: Clinical 
Trials.gov Identifier: NCT02137395. After providing 
written informed consent, in 72 patients (American 
Society of Anaesthesiologist (ASA) physical status: 
I-II; aged 18–65 years) who had undergone an 
elective septoplasty from August 2013 to January 
2015 in Baskent University Faculty of Medicine 
Department of Anesthesiology Clinics were enrolled 
in this study. The exclusion criteria were a history 
of significant cardiac, pulmonary, hepatic or renal 
disease; hypersensitivity to the study medications, 
any disorder contraindicating administration 
of non-opioid analgesics, administration of any 
analgesics 24 hour prior to the study and pregnancy.
 The patients were randomised into two parallel 
groups by a computer-generated random number 
list (http://www.randomization.com) (Fig.1). 
The assigned allocation group was written on 
a note placed inside a numbered envelope (one 
number corresponded to each patient enrolled); the 
envelope was then sealed.
Paracetamol group: 100 ml of an analgesic solution 
containing 1gr of paracetamol was administered as 
an infusion 15 minutes before the surgical incision.
Fig.1: Flow chart of the study design. Administration of 
the study drug was started before the surgery and then 
repeated at 6-h (paracetamol) and 8-h (dexketoprofen) 
intervals for at least 24 h. Scores were then recorded at 24 
h after surgery.
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Dexketoprofen trometamol group: 100 ml of 
an isotonic saline solution containing 50 mg 
dexketoprofen trometamol was administered as an 
infusion 15 minutes before the surgical incision. 
 At the preoperative visit, detailed instructions 
about how to use the PCA device and visual 
analogue scale (VAS) for pain assessment were 
provided to the patients by detail by blinded 
researcher. No premedication was given to the 
patients.
 After admission to the operating room and 
standard anaesthesia monitoring, anaesthesia was 
induced with propofol (2 mg/kg), fentanyl (1µg/kg) 
and Rocuronium (0.1 mg/kg). After endotracheal 
intubation, anaesthesia was continued with 1.5% 
Sevoflurane and a 50% mixture of nitrous oxide and 
oxygen. 
 Postoperative pain intensity was evaluated using 
a VAS; (0 = no pain, 10 = worst pain imaginable) 
at recovery, 15 to 30 min, and 2, 4, 6, 12, and 24 h 
postoperatively. Intravenous tramadol PCA was 
used as a rescue analgesic in both groups. In the 
recovery room, patient’s VAS score was evaluated, 
additional 0.5 mg/kg of tramadol was intravenous 
administered if the score was >3 and intermittent 
intravenous 10 mg of tramadol was administered 
until the score was <3. The requirement of 
tramadol in this time period was recorded. After 
basal analgesia was supplied, PCA was given in 
20-mg boluses with a lockout time of 20 min and 
a four hour  limit arranged to 200 mg via PCA. 
Intravenous paracetamol and dexketoprofen were 
repeated every 6 and 8 h respectively, throughout 
the postoperative period. 
 Each time the VAS score was collected, the degree 
of sedation was determined according to a sedation 
score ranging from 0 to 2 (0 = alert, 1 = drowsy 
but arousable by voice, and 2 = very drowsy, but 
arousable by shaking.11 
 Patient satisfaction was measured using 
5-point Likert Scale (very good, good, sufficient, 
poor, insufficient) at the end of the 24th hour.12 
Additionally, the operation time, additional and 
cumulative tramadol consumption, postoperative 
adverse events and discharge from hospital were 
recorded.
 The primary endpoint of this study was to compare 
the analgesic effects of intravenous dexketoprofen 
with those of paracetamol in combination with 
tramadol PCA during the first 24 hour following 
septoplasty. The secondary end-points were the 
effects of each PCA regimen Tramadol consumption 
and drug related side effects.
Statistical analysis: A priori power analysis was 
performed based on the likely difference in the 
patients’ postoperative pain scores as evaluated 
by the VAS. The sample size was calculated by 
considering the results of our previous study 
of postoperative pain management, which was 
conducted in our otolaryngology clinic and in which 
the VAS was used.13 The results of our previous 
study showed, a mean VAS score of was 6.0±3.7 
without additional analgesics in the postoperative 
period. Using these previous data, we performed 
a power analysis and determined that to detect a 
45% reduction in the VAS scores of patients during 
the postoperative period after administration of 
analgesic drugs with 80% power at a = 0.05, we 
required a sample size of 30 patients per group.
The analysis was performed by Power and Sample 
Size Calculation software (Vanderbilt University, 
Nashville, TN).
 All statistical calculations were performed using 
SPSS for Windows, version 17.0 SPSS Inc., Chicago, 
IL). Differences in numerical variables between 
two groups were evaluated using a t-test or its 
nonparametric counterpart, the Mann–Whitney 
U-test depending on the distribution of variables. 
The Kolmogorov-Smirnov test was used to assess 
the normality of data distribution. Homogeneity of 
variance was calculated using Levene’s test and the 
Lilliefors tests. The chi-squared or Fisher’s exact test 
was used to evaluate the difference in qualitative 
differences. Data are expressed as means ± standard 
deviation or median (interquartile range). A p-value 
of < 0.05 was considered statistically significant.
Analgesic effect of dexketoprofen & paracetamol after septoplasty
Fig.2: Visual analogue scale scores in the two groups 
at the indicated time intervals during the first 24h 
postoperatively. Values are presented as mean ± standard 
deviation. *p<0.05.
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RESULTS
 Seventy-two patients (36 patients in each group) 
were enrolled the study. During the follow-up pe-
riod, two patients in the paracetamol group were 
excluded because of excessive nausea. Thus, 70 
patients (paracetamol group, 34 patients; dexke-
toprofen group, 36 patients) constituted the study 
population.There were no statistically significant 
differences with respect to age, sex, weight, dis-
charge of hospital, duration of anaesthesia or sur-
gery between the two groups (Table-I).
 Comparison of the groups at recovery, 15 and, 
30 minutes, 1, 2, 4, 6, 12, and 24 hour showed that 
the VAS scores in the dexketoprofen group were 
significantly lower than those in the paracetamol 
group at recovery, 15 and, 30 minutes and two hour 
(p < 0.05) (Fig.2). There was no significant difference 
in pain scores at any other time points.
 Tramadol consumption during the recovery 
period was higher in paracetamol group, but not 
significantly different between the paracetamol and 
dexketoprofen groups (Table-II). The total tramadol 
consumption was calculated by multiplying the 
number of deliveries at the end of the 24th hour by 
the number of boluses (PCA demand and delivery 
values). There was also no significant difference in 
the total tramadol consumption, or, demand and 
delivery values between the two groups (Table-II).
 During the postoperative 24 hour follow-up 
period, the two groups exhibited similar sedation 
scores, and the degree of sedation in all patients 
was generally determined to be mild during the 
recovery period and alert during the service follow-
up period (p > 0.05).
 Although the incidence of nausea was lower in 
dexketoprofen than paracetamol group during the 
postoperative in 24-h hours follow-up period, it was 
not statistically significant (p > 0.05). Thus, there is 
no statistically significant difference in vomiting 
and other side effects (Table-III). 
 The overall degree patient’s satisfaction was 
determined to very good and good in both groups 
and there was a significant difference in patient 
satisfaction between the two groups. The number 
of patients who were very good was significantly 
higher in Group-II (29 patients) than in Group-I (6 
patients).
DISCUSSION
 During the last 20 years, despite our increased 
knowledge of the pathophysiology of nociception 
and pharmacological alternatives for the treatment 
of pain remains a problem in many cases. Therefore, 
in recent years, multimodal or, “balanced” analgesic 
techniques with non-opioid analgesic drugs such as 
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Table-I: Patients demographic data
and surgical characteristics.
Paracetamol 
(n=34)
Dexketo-
profen 
(n=36)
Sex (male / female) 
Age (y)
Weight (kg)
Height (cm)
Body mass index
ASA physical status (I/II)
Duration of surgery (min)
Discharge of hospital (hour)
21/13
35± 13.3
76.2 ± 12.8
168 ± 7
27.1 ± 5.5
30/4
75 (55-90)
23 ± 3.2
26/10
32.3±11
75.2±14.9
166 ± 8
26.6 ± 5.3
28/8
70 (60-87.5)
22.9 ± 2.5
Values are presented as n, mean ± standard deviation, 
and median (interquartile range). 
ASA: American Society of Anesthesiologist.
Table-II: Postoperative tramadol consumption and PCA delivery and demand values.
Paracetamol Dexketoprofen p
Duration of PACU (min) 39.1±10.4 32.3±6.3* 0.002*
Tramadol consumption at recovery (mg) 53.8±28.7 40±23.5 NS
Cumulative tramadol consumption (mg) 131.7±78.6 119±70 NS
PCA delivery (n) 6 (3-9) 5.5 (3.5-8.5) NS
PCA demand (n) 9 (5-11) 7 (4-11.5) NS
NS: Not significant, *: p<0.05. Values are presented as n, mean ± Standard deviation or median 
(interquartile range). PCA, patient-controlled analgesia; PACU, post-anesthesia care unit.
Table-III: Incidence of side effects in each groups.
Paracetamol Dexketoprofen
Nausea 12 (35.2) 5 (13.8 )
Vomiting 2 (5.8) 0
Gastric pain 1(2.9) 0
Gastrointestinal 
bleeding 1 (2.9) 0/36
Headache 3 (8.8) 1 (2.7)
 Data are presented as n (%).
paracetamol and various NSAIDS in combination 
with lower doses of opioids are preferred for 
perioperative analgesia.14 Dexketoprofen and 
paracetamol, including in their intravenous forms 
are other analgesics that have been increasingly 
used in recent years too.7,15,16 
 In the present study, we analysed the effect 
of intravenous dexketoprofen trometamol and 
paracetamol administered at 24-h intervals 
on postoperative analgesic efficacy, tramadol 
consumption and side effects. Patients in 
dexketoprofen group had lower VAS scores in 
recovery, at 15 and, 30 minutes, and at two hour 
than patients in the paracetamol group; they also 
had lower consumption of tramadol in the recovery 
period than patients in the paracetamol group.
 NSAIDs are widely used as supplemental 
analgesics, however, they should be carefully 
used because of their potential adverse effects 
including renal and gastrointestinal side effects, 
bone marrow suppression, and postoperative 
bleeding.17Dexketoprofen and paracetamol, 
including in their intravenous forms are other 
analgesics that have been increasingly used in 
recent years.7,15,16
 Intravenous paracetamol is commonly used 
analgesic for acute postoperative pain management. 
Paracetamol exhibits central inhibition of 
cyclooxygenases and interact with seratoninergic 
system18 and does not include have the side effects 
seen with NSAIDs. The effects of intravenous 
paracetamol on postoperative pain have been 
previously studied in different surgeries and 
also evaluated and demonstrated opioid-sparing 
effects.16,19 
 Broadner et al.19 showed that the analgesic 
efficacy of paracetamol is not different from the 
efficacy of dipyrone and parecoxib when used 
to provide postoperative analgesia after various 
surgical procedures. Therewithal, Korkmaz et al.20 
demonstrated that 1g IV pre-emptively  paracetamol 
in addition to morphine PCA provided effective 
equivalent analgesia to 1g of metamizole after 
lumbar disc surgery.
 In our study, we used 1g IV paracetamol and 
but, we could not show any reduction in pain 
scores and tramadol consumption compared 
with dexketoprofen.Ketoprofen is an NSAID 
with analgesic properties, but it also has severe 
gastrointestinal side effects. Dexketoprofen 
trometamol is an active enantiomer of racemic 
ketoprofen which has equivalent analgesic efficacy 
with less severe side effects than ketoprofen.10 
The analgesic efficacy of oral or intramuscular 
dexketoprofen on moderate and severe pain 
have evaluated in previous studies10,21,22 and 
demonstrated lower VAS scores and opioid 
consumption in the dexketoprofen group than in 
the control group.22 
 In recent years, the parenteral formulation 
of dexketoprofen has been improved and now 
demonstrates adequate and safe analgesic 
properties and tolerable side effects in various 
surgical procedures.18  Ozer et al.23 compared 
the analgesic efficacy and side effect profile of 
preoperative and/or intraoperative intravenous 
administration of dexketoprofen with those in a 
control after septorhinoplasty. The dexketoprofen 
group exhibited significant analgesic efficacy with 
lower VAS scores, less severe side effects, and good 
patient complacence.
 In literature, there are several studies which  have 
compared the effects of intravenous paracetamol 
and dexketoprofen on postoperative pain.16 But, the 
number of studies use these drugs in combined with 
patient-controlled analgesia is more limited.16,24
 Tunali et al.16 compared the analgesic effect 
of intravenous paracetamol with that of 
dexketoprofen on postoperative pain after lumbar 
disc surgery. This study showed that pain intensity 
was significantly lower with dexketoprofen as a 
supplemental analgesic to morphine PCA when 
compared with the control group during the first 
24 hour postoperatively. In the same study, there 
was no difference in the pain scores when the 
dexketoprofen group was compared with the 
paracetamol group.
 In our study, the VAS scores in the dexketoprofen 
group were significantly lower than those in the 
paracetamol group at recovery, 15 and, 30 min 
and 2 h (p < 0.05). This difference can be explained 
by having more patients in our study and by the 
difference in the type of surgery.
 These results also indicate that dexketoprofen 
provides more effective analgesia in the early 
postoperative period after septoplasty than does 
paracetamol. The low consumption of opioids 
during the recovery period also supports these 
results. 
 Although, in the present study, we found that 
dexketoprofen reduced the intensity of pain in the 
early follow-up period  and opioid requirement 
in recovery period, but cumulative tramadol 
consumption between two groups were not 
significantly different when used as a supplemental 
analgesic to tramadol PCA.
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 A possible explanation for these findings might 
be that the sample size in our study was not large 
enough to detect substle differences. Our power 
analysis was based on the assumption that 45 % 
decrease in pain score on a VAS clinically relevant 
and should be primary outcome measure, but 
this might be sufficiently large to detect tramadol 
consumption.
 Postoperative nausea and vomiting is among the 
most common postoperative side effects following 
general anaesthesia. The addition of the NSAIDs to 
multimodal analgesia protocols, while reducing the 
side effects associated with opioids, can also cause 
gastrointestinal side effects of their own.4
 In previous studies involving different types of 
surgery, dexketoprofen possessed good analgesic 
efficacy and a high tolerability profile with lower 
gastrointestinal side effects. 
 Yazar et al.8 compared dexketoprofen with 
a control drug in 60 patients who underwent 
lumbar disc surgery. The authors found that 50 
mg intravenous dexketoprofen administered 
intraoperatively and at 12 hour postoperatively 
was an effective analgesic that decreased opioid 
consumption and opiod-related side effects. These 
findings also support the results of our study.
 In our study, a supplemental analgesic used 
occurred more frequently in the paracetamol than 
dexketoprofen group. In addition to significantly 
lower pain scores and lower opiod consumption 
with dexketoprofen than paracetamol, we also found 
lower incidence of nausea in the dexketoprofen 
group, but without statistical significance. We 
believe that a statistical difference could be reached 
by increasing the sample size, which is a limiting 
factor in our study. Likewise, we believe that the 
high incidence of nausea in the paracetamol group 
can also be explained of the higher opioid dose for 
supplemental analgesia. Intravenous dexketoprofen 
given with tramadol PCA was better tolerated than 
paracetamol. The other side effects and sedation 
scores did not differ between two groups.In our 
study, the overall degree patient’s satisfaction was 
determined to very good and good in both groups. 
The number of patients who were very satisfied 
was significantly higher in dexketoprofen group 
which we thought have been associated with the 
lower incidence of nausea.
CONCLUSION
 The concept of preemptive analgesia remains 
an important research topic for postoperative 
pain relief. The results of our study show that 50 
mg of dexketoprofen trometamol administered 
15 minutes before the surgical incision and the 
during the first 24h postoperatively (every 8 h) is 
an effective analgesic that lowers pain scores and, 
decreases opioid consumption and opioid related 
side effects compared with paracetamol in patients 
undergoing septoplasty. Effective postoperative 
pain relief, the opioid sparing effect, and the low 
incidence of side effects with dexketoprofen may be 
one main reason to use this drug as an alternative 
to paracetamol. We feel that, further controlled 
studies comparing intravenous dexketoprofen with 
other NSAIDS and using different dose regimens 
are needed to determine the efficacy and safety 
profile of dexketoprofen.
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